CURRICULUM VITAE

 

 

JODY L. SINDELAR                                                                      March 2007

 

Yale School of Medicine                                          Phone: (203) 785-5287
Yale School of Public Health                                           Fax:     (203) 785-6287

Institution for Social and Policy Studies (Yale)            E-mail: jody.sindelar@yale.edu

National Bureau of Economic Research

60 College Street, Room 306                

P.O. Box 208034

New Haven, CT  06520-8034

 

 

Education

 

 

 

Academic Appointments

 

1980–1984    Assistant Professor of Business Economics, University of Chicago Graduate School of Business

1984–1989    Assistant Professor, Yale School of Public Health, Yale School of Medicine

1984–           Joint Appointment, Institution for Social and Policy Studies, Yale University (for the purpose of teaching a course)

Spring 1988  Joint Appointment, Adjunct Faculty, Yale School of Management

1989–1995    Associate Professor (without tenure), Yale School of Public Health, Yale School of Medicine

1992–1998    Co-Director, AHCPR, National Research Service Award, “Yale’s Training Program in Health Services”

1995–2004    Associate Professor (with tenure), Yale School of Public Health, Yale School of Medicine, and Yale Graduate School

1999–2004    Director, AHCPR, National Research Service Award, “Yale’s Training Program in Health Services”

1995–1997    Associate Dean, Yale School of Public Health

2004–           Professor (with tenure), Yale School of Public Health, Yale School of Medicine, and Yale Graduate School

2005–           Head, Division of Health Policy and Management, Yale School of Public Health

 

 

 

Professional positions prior to PhD awarded.

 

1975–1977    Economist in the Office of Income Security Policy, Assistant Secretary for Planning and Evaluation/Research, Department of Health, Education and Welfare, Washington, DC

1978             Economist at Public Services Laboratory, Georgetown University

1978–1980    Post-Doctoral Fellow, sponsored by Professors Gary S. Becker (Nobel Laureate) and T.W. Schultz (Nobel Laureate), Department of Economics, University of Chicago

1979             Lecturer, Department of Economics, University of Chicago

1980 (Fall)    Visiting Assistant Professor, Boston University, School of Management

 

 

Professional Service, Honors, and Recognition

 

Ø       President and founding member, American Society for Health Economics (ASHE), 2006 to present

Ø       President-elect, founding member, American Society for Health Economics (ASHE), 2005 to 2006; Chair of the Scientific Program at inaugural meeting of ASHE in Madison, Wisconsin, June, 2006. Awarded a NIDA grant for the conference

Ø       Editorial Board, Drug Policy Analysis Bulletin, 2006 to present

Ø       Editorial Advisory Board, Journal of Mental Health Policy and Economics 2006 to present

Ø       Editorial Board, Health Economics 2005 to present

Ø       Director, AHCPR, National Research Service Award, “Yale’s Training Program in Health Services”, 1999 to 2004

Ø       National Bureau of Economic Research, Research Associate (by appointment) 1993 to present

Ø       NIAAA Career Development Award, Research Scientist Career Development Award (K02 award), 1993 to 1998

Ø       Co-Director, AHCPR, National Research Service Award, “Yale’s Training Program in Health Services”, 1992 to 1998

Ø       Director, Agency for Health Care Policy and Research Training Grant, Yale University,1995 to 1997, Co-Director 1992-1995

Ø       International Health Economic Association (iHEA), Program and Scientific Committee, 1998, 2003 and 2005; and Student Paper Awards committee, 2005

Ø       Arrow Award Committee in Health Economics, 1997 to 2004.

Ø       Chair and Member, Health Economics Panel, New York State Department of Health, one of four economists on rate making body setting price increases for all hospitals and nursing homes in New York State; Panel, June 1993 to 1997, Chair, August 1987 to 1995

Ø       Editor and founder of Medical Economics Group, a Yale University Institution for Social and Policy Studies working paper series, 1985 to 1989

Ø       Post-Doctoral Fellow, sponsored by Professors Gary S. Becker (Nobel Laureate) and T.W. Schultz (Nobel Laureate), Department of Economics, University of Chicago, 1978 to 1980

Ø       NMIH Post-Doctoral Fellowship, 1978 to 1980

Ø       Fellowship, Stanford University, 1975 to 1977

 

 

Review Committees

         

Ø       Scientific Review Committee for the Yale-Donaghue Programs on Women’s Health, 1998 to present

Ø       Tobacco-Related Disease Research Program, Review Committee, 2003

Ø       Scientific Review Committee of the Clinical Trial Network, 2000 to present

Ø       Reviewer, Robert Wood Johnson Substance Abuse, 2001 to 2005

Ø       Study Section Member, National Institute of Drug Abuse (NIDA) Treatment and Prevention Studies Committee, 1997 to 2003

Ø       Agency for Health Care Policy and Research, Special Review on Managed Care, 1995

Ø       National Sciences Foundation, 1994 to 1996

Ø       Reviewer for National Sciences Foundation, 1994 to 1995

Ø       National Institute on Alcoholism and Alcohol Abuse, Study Section, Prevention and Epidemiology, Ad Hoc, 1994

Ø       Agency for Health Care Policy and Research, Ad Hoc Committee to review training grant applications, May 1993

Ø       National Institute on Aging, Ad Hoc Review Committee, November 1993

Ø       National Institute on Alcoholism and Alcohol Abuse, Ad Hoc Reviewer for Prevention and Epidemiology, October 1992

Ø       National Institute on Alcoholism and Alcohol Abuse, Study Section, Prevention and Epidemiology, Ad Hoc, 1992, and NIAAA Ad Hoc, 1994

Ø       National Institute on Drug Abuse, Concept Review Committee: "Research Centers on Health Services, Research for Drug Abuse and Drug Problems," and "Managed Care of Substance Abuse Treatment", January 1991

Ø       Health and Retirement Survey, Ad Hoc Committee, National Institute on Aging, July 1990

Ø       Economics Special Review Committee, National Institute on Alcoholism and Alcohol Abuse, November 1990

 

 

Advisory Boards and Boards of Directors

 

Ø       Executive Board, Transdisciplinary Tobacco Use Research Yale center, and Center for Nicotine Use and Research at Yale, CENTURY, 2001 to present

Ø       Executive Board, Psychosocial Psychotherapy Development Research Center for Cocaine and Opioid Abuse, 2003 to present.

Ø       Senior Scientific Committee, New England Node of the Clinical Trial Network, 2000 to present

Ø       Yale School of Medicine’s Commission on Women Faculty, 2004 to present

Ø       Advisory Board, MUSC, 2003

Ø       Advisory Board, National Treatment Outcomes Monitoring System, Center for Substance Abuse Treatment, 2002 to 2003

Ø       Board of Directors, Eli Whitney Museum, 2000 to 2003

Ø       Advisory Board, University of Miami, Economic Evaluation Methods: Development and Applications, 1999 to present

Ø       Advisory Board, Research Triangle Institute, Substance Abuse grant, 1994 to 1995

Ø       Board Member, Health Care Policy and Regulation Workshop, funded by Robert Wood Johnson, Tom Abbott, Director, 1993 to 1995

Ø       Board of Directors, Alcohol Services Organization of South Central Connecticut, 1992 to 1995

Ø       Board of Directors, Calvin Hill Day Care Center, 1989 to 1994

Ø       Board of Directors, Shirley Frank Foundation, Alcohol and Drug Treatment Center, New Haven, CT 1988 to 1990

 

Appointed Member of Government Task Forces

 

Ø       Member, CT Alcohol and Drug Policy Council, Non-statutory Professional Resource Member, 1998 to 2002

Ø       Chair, Yale Seminar Series for Connecticut Legislation, Charles E. Culpepper funding, 1997 to 1999

Ø       Member, Working Group on Methadone Treatment for the Drug Policy Study for the Connecticut Law Revision Commission, 1996 to 1997

Ø       Member, Governor's Blue Ribbon Panel on Addiction, CT, 1995 to 1996

Ø       Chair and Member, Health Economics Panel, New York State Department of Health, one of four economists on rate making body setting price increases for all hospitals and nursing homes in New York State.  Panel June 1993 to 1997, Chair August 1991 to 1996

 

         

Program Faculty at Yale

 

Ø       Program Faculty, Yale’s Drug Abuse Clinician Scientist (K12) program, 2003 to present.

Ø       Program Faculty, Yale’s BIRCWH training program in substance abuse and women’s health, 2004 to present.

Ø       Program Faculty, Robert Wood Johnson Clinical Scholars Training Grant, Yale University, Alvan Feinstein and Ralph Horwitz, Directors, 1994 to 2000

Ø       Program Faculty, Program on Aging and Claude D. Pepper Older American Independence Center, Yale University, Lisa Berkman and Mary Tinetti, Directors, 1994 to 1998

Ø       Program Faculty, National Institute of Mental Health, Mental Health Services Systems Research Training Grant, Sarah M. Horwitz, Director, 1994 to 2004.

Ø       Program Faculty, Robert Wood Johnson Policy Scholars, Theodore Marmor, P.I., Yale University, 1993 to1997

 

 

Professional Advising

 

Ø       Consultant, Baltimore Needle Exchange research grant, 2002

Ø       Center for Substance Abuse Prevention Data Coordinating Center, SAMSA, 2001

Ø       Bristol Meyer Squibb, 1995

Ø       Bureau of Labor Statistics, Department of Labor, 1994

Ø       Center on Addiction and Substance Abuse, Columbia University, 1994

Ø       Parke-Davis Pharmaceutical Company 1993

Ø       Office of Applied Studies, Substance Abuse and Mental Health Services (SAMHSA), Bethesda, MD, November 1993

Ø       Bureau of Health Professionals, US Public Health Service, USDHHS, 1990

Ø       National Institute on Alcoholism and Alcohol Abuse May 1989

Ø       Federal Trade Commission 1989

Ø       American Psychiatric Association 1987

Ø       Veterans Administration (Washington DC) 1987

Ø       Various law firms (Hubbard, O'Brien and Hall; Rothschild, Barry, and Meyers; Horan Associates; and Rosen and Dolon; various times from 1980 to 1992)

 

 

Professional Organizations

 

Ø       American Society for Health Economics (ASHE), 2003 to present; currently President.

Ø       Committee on the Status of Women in the Economics Profession, 1980 to present

Ø       American Economic Association, 1980 to present

Ø       Research Society on Alcoholism, 1993 to 1996

Ø       Association for Public Policy Analysis and Management, 1991 to 1995

Ø       Population Association of America, 1990 to present 1994

Ø       Association for Health Services Research, 1989 to present 1996

Ø       American Public Health Association, 1986 to present 1900

Ø       Health Economics Research Organization, 1983 to 1991

Ø       Health Economics Forum, 1982 to 1985

Ø       Society for the Study of Addiction to Alcohol and Drugs, 1993 to 1995

 

 

Teaching – Courses  taught at Yale, 1994 – Present

 

Ø       HPA 510a, Health Policy Core Course, 1994

Ø       HPA 587a, Advanced Health Care Economics, 1993-1998

Ø       HPA 617a/HPA650a Joint Colloquium in Health Policy and Health Services Research and Mental Health Services Research 2001 to present

Ø       HPA 589b, Economics of Alcohol, Drugs and Crime, Spring 2000

Ø       HPA 600b, Doctoral Reading Seminar, Spring 1994

 

Also served as advisor for Masters and Ph.D. students and advisor and reader for Masters essays and Ph.D. dissertations.

 

 

Teaching Courses – Other

 

Ø       Microeconomics:     Yale School of Management, 1988

Ø       Microeconomics:     Boston University, 1980

Ø       Labor Economics:    University of Chicago, Graduate School of Business, 1980-1984

Ø       Health Economics:   University of Chicago, Economics Department, 1979, 1980

 

 

Publications

 

1.       Sindelar JL. Value of Time and the Use of Medical Care. Socioeconomic Issues in Health, edited by Douglas E. Hough and Robert Musacchio, American Medical Association, Chicago, 1981; pp. 51–75.

2.       Sindelar JL. Differential Use of Medical Care by Sex. Journal of Political Economy October 1982; 90(5): 1003–1019.

3.       Sindelar JL. Behaviorally Caused Loss of Health and the Use of Medical Care. Economic Inquiry July 1982; 20(3): 458–471.

4.       Dranove D, Satterthwaite M, and Sindelar JL. Preferred Provider Organizations: Injecting Price Competition into the Hospital Market. Inquiry Winter 1986; 23(4): 419–431.

5.       Ibottson R and Sindelar JL. Evergreen Industries: Setting Pension Fund Objectives. Journal of Management Case Studies Summer 1986; 156–163.

6.       Greany TL and Sindelar JL. Preferred Provider Organizations: Assessing the Anticompetitive Risks. Inquiry Winter 1987; 24(4): 384–391.

7.       Greany TL and Sindelar JL. Physician-Sponsored Joint Ventures: An Antitrust Analysis of Preferred Provider Organizations. Rutgers Law Journal Spring 1987; 18(3): 513–589.

8.       Sindelar JL. The Declining Price of Health Insurance. The Political Economy of Health Care, edited by H.E. Frech III, Pacific Institute for Public Policy Research and Ballinger, 1987; 259–292.

9.       .Investing in a Time of Uncertainty. Off Hours 1987; 4(7): 35–39

10.   Ibbotson R, Ritter J, and Sindelar JL. Initial Public Offerings: From Venture Capital to Public Market. Journal of Applied Corporate Finance Summer 1988; 37–45.

o      Reprinted in New Developments in Commercial Banking, edited by Donald Chew, Blackwell Publishers, 1991.

o      Reprinted in New Corporate Finance, edited by Don Chew, McGraw Hill, 1993.

11.   Mullahy J and Sindelar JL. Lifecycle Effects of Alcoholism on Education, Earnings, and Occupation. Inquiry Summer 1989; 26(2): 272–282.

12.   Sindelar JL. Total Return versus Yield in Health Care Investments. Healthcare Financial Management May 1989; 121–123.

13.   Mullahy J and Sindelar JL. An Ounce of Prevention: Productive Remedies for Alcoholism. Journal of Policy Analysis and Management Spring 1990; 9(2): 249–253.

14.   Lachs M, Sindelar JL, and Horwitz R. The Forgiveness of Co-insurance: Charity or Cheating. New England Journal of Medicine May 31, 1990; 322(22): 1599–1602.

15.   Horwitz R, Viscoli C, Berkman L, Donaldson R, Horwitz S, Murray C, Ransohoff D, and Sindelar JL. Treatment Adherence and The Risks of Death After a Myocardial Infarction. Lancet September 1, 1990; 1:542-545.

16.   Mullahy, J. and Sindelar JL. The Effects of Mental Health on Labor Force Participation: Gender Differences. Research in Human Capital and Development: Female Labor Force Participation, edited by Ismail Sirageldin, JAI Press, Greenwich, CT., 1990; 125–146.

17.   Sindelar JL. Economic Costs of Illicit Drugs: Commentary and Critique. Economic Costs, Cost-Effectiveness, and Financing of Community Based Drug Treatment, National Institute on Drug Abuse Research Monograph Series. 1991; 33–45. 

18.   Mullahy J and Sindelar JL. Gender Differences in Labor Market Effects of Alcoholism. American Economic Review May 1991; 161–165.

19.   The Economics of Women's Health. Women's Studies Encyclopedia, edited by Helen Tierney, Peter Bedrick Press 1991; 165–167.

20.   Brown E, Smith D, and Sindelar JL. Can We Regulate the Quality of Care? The Case of Dialysis in Connecticut. American Journal of Kidney Disease June 1992; 19(6): 609–613.

21.   Mullahy, J and Sindelar JL. The Economics of Alcohol and Labor Markets Productivity, Income, Schooling, and Employment. Alcohol, Health, and Research World 1992; 6(2): 134–139.

22.   Sindelar JL. Measurement Issues in Alcohol Survey Data. Economic Research on the Prevention of Alcohol Related Problems, NIAAA monograph, edited by Greg Bloss and Michael Hilton. 1993; NIH Publication No. 93-3513: 201–228.

23.   Mullahy J and Sindelar JL. Alcoholism, Work and Income Over the Life Cycle. Journal of Labor Economics 1993; 11(3): 494–520.

24.   Grossman M, Sindelar JL, Mullahy J, and Anderson R. Policy Watch: Alcohol & Cigarette Taxes. Journal of Economic Perspectives Fall 1993; 7: 211–222. 

o      Reply: Grossman M, Mullahy J, and Anderson R. Journal of Economic Perspectives Winter 1995; 220–212.

o      Reproduced in Readings in Public Finance, edited by Samuel H. Baker and Catherine S. Elliot, Southwestern Publishing.

  1. Brown E and Sindelar JL. Is It Urgent? Misuse of Ambulance Services. Annals of Emergency Medicine April 1993; 22(4): 17–21.
  2.  Ibbotson R, Ritter J, and Sindelar JL. The Markets' Problems with the Pricing of Initial Public Offerings. Journal of Applied Corporate Finance Summer 1994; 66–74.

o      Reprinted in The Investments Reader, Second Edition, Kolbe Publishing Company.

  1.  Mullahy J and Sindelar JL. The Direct and Indirect Effects of Alcoholism on Income. Milbank Quarterly 1994; 72(2): 359–375.
  2.  Mullahy J and Sindelar JL. Do Drinkers Know When to Say When? An Empirical Analysis of Drunk Driving. Economic Inquiry 1994; 32(3): 383–394.
  3. Mullahy J and Sindelar JL. Health Capital, Risk Aversion, and the Variance of Income: Assessing Some Welfare Costs of Alcoholism and Poor Health. Journal of Human Resources 1995; 30(2): 439–459.
  4. Rosenheck R, Frisman L, and Sindelar JL. Disability Compensation and Work: A Comparison of Veterans with Psychiatric and Non-Psychiatric Impairment. Psychiatric Services April 1995; 46(4): 359–364.
  5. Rizzo J and Sindelar JL. Medical Practice Guidelines and Efficient Allocation of Resources. Health Care Policy and Regulation, edited by Thomas A. Abbott, III. Kluwey Academic Publishers, 1995; 183–200.
  6. Sindelar JL. The Effects of Alcoholism on Women's Labor Market Outcomes. Alcohol and Women: Issues for Prevention Research, edited by Jan M. Howard, Susan E. Martin, Patricia Mail, Michael Hilton and Elsie Taylor, 1996; NIH, NIAAA, Research Monograph No. 32, 291–314.
  7. Rizzo J and Sindelar JL. Optimal Regulation of Multiply-regulated Industries: The Case of the Physician Services Market. Southern Economic Journal April 1996; 62(4): 966–978.
  8. Mullahy J and Sindelar JL. Employment, Unemployment, and Problem Drinking. Journal of Health Economics 1996; 15(4): 387–512.
  9. Sindelar JL and Manning W. Cost-Benefit and Cost-Effectiveness Analysis:  Issues in the Evaluation of the Treatment of Illicit Drug Abuse. Treating Drug Abusers Effectively edited by J. Egertson, D. Fox and A. Lesher, Milbank/Blackwell. 1997; 187-222.
  10. Sindelar JL. Cost-Benefit and Cost-Effectiveness Analyses: Issues in the Evaluation of the Treatment of Illicit Drug Abuse, with Will Manning, Jr. in Treating Drug Abusers Effectively, edited by Joel Egertson, Daniel Fox and Alan Leshner, Milbank/Blackwell, 1997; 187–222.
  11. Rizzo J and Sindelar JL. Coordination Defaillante en Presence de Regulateurs Multiples: Le Cas des Medecins. Economie de la Sante: Trajectories du Futur, edited by de Stephane Jacobzone, INSEE, 1997; 362–369.
  12. Margolin A, Avants K, Kosten T, and Sindelar JL. Psychosocial Treatments for Methadone Patients: Is More Treatments Necessarily Better? Problems of Drug Dependence (NIDA Research monograph) 1997.
  13. Mullahy, J. and Sindelar JL. Drinking, Problem Drinking and Productivity. Recent Developments in Alcoholism 1998; Vol. 14.

o      The Consequences of Alcoholism: Medical, Neuropsychiatric, Economic, Cross-Cultural, edited by M. Galanter, American Journal of Psychiatry April 2000; 157(4): 653.

o      Mullahy J and Sindelar JL. Women and Work: Tipplers and Teetotalers. Health Economics 1997; 6(5): 533–537.

o      Reprinted in Electronic Health Economics Letters 1997; 1(3).

  1. Sindelar JL. Social Costs of Alcohol. Journal of Drug Issues Summer 1998; 28(3): 763–781.
  2. Rizzo J, Pashko S, Friedkin R, Mullahy J, and Sindelar JL. Linking the Health Utilities Index to the National Medical Expenditure Survey Data. Pharmacoeconomics May 1998; 13(5): 531–41.
  3. Avants K, Margolin A, Sindelar JL, Rounsaville BJ, et al. Day Treatment Versus Enhanced Standard Methadone Services for Opioid-Dependence Patients: A Comparison of Clinical Efficiency and Cost. American Journal of Psychiatry January 1999; 156: 27–33.
  4. Rizzo J and Sindelar JL. Linking Health-related Quality-of-Life Indicators to Large National Data Sets. Pharmacoeconomics November 1999; 16(5 Pt. 1): 473–82.
  5. French MT, Roebuck M, McLellan AT, and Sindelar JL. Can the Treatment Services Review (TSR) Used to Estimate the Costs of Addiction and Ancillary Services? Journal of Substance Abuse Winter 2000; 12(4): 341–361.
  6. Sindelar JL and Fiellin D. Innovations in Treatment for Drug Abuse. Annual Review of Public Health 2001; 22: 249–72.
  7. Jofre-Bonet M and Sindelar JL. Drug Treatment as a Crime Fighting Tool. Journal of Mental Health Policy and Economics December 2001; 4(4): 175–188.
  8. French MT, Salome HJ, Sindelar JL, and McLellan AT. Benefit-Cost Benefit Analysis of Addiction Treatment: Methodological Guidelines and Application Using the DATCAP and ASI. Health Services Research April 2002; 37(2): 433–456.
  9. Akazawa M, Sindelar JL, and Paltiel AD. Economic Costs of Influenza-related Work Absenteeism. Value in Health 2003; 6(2): 107–115.
  10. Falba T, Jofre-Bonet M, Busch S, Duchovny N, and Sindelar JL. Reduction of Quantity Smoked Predicts Future Cessation Among Older Smokers. Addiction January 2004; 99(1): 83–102.
  11. Olmstead TA, White WT, and Sindelar JL. The Impact of Managed Care on Substance Abuse Treatment Services. Health Services Research April 2004; 39(2): 319–344.
  12. Jofre-Bonet M and Sindelar JL. Health Outcomes Index for Evaluating Substance Abuse Treatment. Journal of Behavioral Health Services 14 May 2004; 31(3): 229–241.
  13. Sindelar JL, Jofre-Bonet M, French MT, and McLellan AT. Cost Effectiveness Analysis of Addiction Treatments for Illicit Drug Dependence: Paradoxes with Multivariate Outcomes. Drug and Alcohol Dependence 2004; 73(1): 41–50.
  14. Jofre-Bonet M, Sindelar JL, Petrakis I, Nich C, Frankforter T, Rounsaville BJ, and Carroll K. Cost-Effectiveness of Disulfiram: Treating Cocaine use in Methadone-Maintained Patients. Substance Abuse Treatment 2004; 26: 225–232.
  15. Olmstead TA and Sindelar JL. To What Extent Are Key Services Offered in Treatment Programs for Special Populations? Journal of Substance Abuse Treatment 2004; 27: 9–15.
  16. Snyder A, Falba T, Busch S, Sindelar JL. Are State Legislatures Responding to Public Opinion When Allocating Funds For Tobacco Control Programs? Health Promotion Practice (Theme Issue), 3 July 2004; supplement to 5(3): 35s-45s.
  17. Jofre-Bonet M. and Sindelar JL. Creating an Aggregate Outcome Index: Cost-effectiveness Analysis of Substance Abuse Treatment. Journal of Behavioral Health Services & Research 2004; 31(3): 229–241.
  18. Busch S, Falba T, Duchovny N, Jofre-Bonet M, O’Malley S, and Sindelar JL. Value to Smokers of Improved Cessation Products:  Evidence from a Willingness-To-Pay Survey. Nicotine and Tobacco Research August 2004; 6(4): 631-639.

58. Sindelar JL and Falba T. Securitization of Tobacco Settlement Payments to Reduce States’ Conflict of Interest. Health Affairs September/October 2004; 23(5): 188–193.

59. Dodge R, Sindelar JL, and Sinha R. The role of depression symptoms in predicting drug abstinence in outpatient substance abuse treatment. Journal of Substance Abuse Treatment 2004; 28: 189–196.

60. Sindelar JL. and Olmstead T. Illicit drug use and drug-related crime Elgar Companion to Health Economics, 2005; edited by A. Jones, Edward Elgar Publishing, Brookfield, VT.

  1. Sindelar JL, Duchovny N, Falba T, and Busch S. If Smoking Increases Absences, Does Quitting Reduce Them? Tobacco Control 2005; 14: 99–105.

62. Busch S, Jofre-Bonet M, Falba T, and Sindelar JL. Burning a hole in the budget: Tobacco spending and its crowd-out of other goods. Applied Health Economics and Health Policy 2005; 3(4): 263–272.

  1. Falba T, Teng H-M, Sindelar JL, and Gallo WT. The Effect of Involuntary Job Loss on Smoking Intensity and Relapse. Addiction April 2005; 100(9): 1330–1339.
  2. Olmstead TA, Johnson A, Roman P, and Sindelar JL. What are the correlates of substance abuse treatment counselor salaries? Journal of Substance Abuse Treatment 2005; 29: 181–189.
  3. Sindelar JL and Olmstead T. Managed Care’s Dual Impact on Outpatient Substance Abuse Treatment: Methadone Maintenance vs. Drug Free. Journal of Drug Issues 2005; 35(3): 507–528.
  4.  Jofre-Bonet M, Busch SH, Falba TA, and Sindelar JL. Poor Mental Health and Smoking: Interactive Impact on Wages. The Journal of Mental Health Policy and Economics December 2005; 8(4): 193–203.
  5. Olmstead T and Sindelar JL. Does the impact of managed care on substance   abuse treatment services vary by profit status? Health Services Research December 2005; 40(6 Pt 1): 1862–1882.
  6. Wang H, Busch S, and Sindelar JL. The Impact of Tobacco Expenditure on   Household Consumption Patterns in Rural China. Social Science & Medicine March 2006; 62(6): 1414–1426.
  7. McCarty D, Sindelar JL, et al. The Direct Care Workforce in the National Drug Abuse Treatment Clinical Trials Network: Characteristics, Opinions and Beliefs. Psychiatric Services 2006; In Press.
  8. Busch S, Barry C, Vegso S, Sindelar JL, and Cullen M. Effects of a Cost-Sharing Exemption on Use of Preventive Services at One Large Employer. Health Affairs 2006; 25(6):1529-1536.
  9. Olmstead TA, Sindelar JL, Petry N. Cost-effectiveness of Prize Based Incentives for Stimulant Abusers in Outpatient Psychosocial Treatment Programs. Drug and Alcohol Dependence Online September 8, 2006. doi:10.1016/j.drugalcdep2006.08.012.
  10. Rosenheck RA, Leslie D, Sindelar JL, et al., Cost-effectiveness of Second Generation Antipsychotics and Perphenazine in a Randomized Trial of Treatment of Chronic Schizophrenia. American Journal of Psychiatry December 2006; 163(12): 2080-2089.   
  11. McCarty D, et al. Sindelar JL. Direct Care Workers in the National Drug Abuse Treatment Clinical Trials Network: Characteristics, Opinions and Beliefs. Psychiatric Services 2007; 58(2):181-190.
  12. Sindelar JL, Brian Elbel, and Nancy M. Petry. What do we get for our money? Cost-effectiveness of adding contingency management. Addiction 2007; 102(2):309-316.
  13. Olmstead TA, Johnson JA, Roman PM, and Sindelar JL. Why are SAT counselors in recovery paid less? Journal of Behavioral Health Services & Research, forthcoming.
  14. McKee S, Falba TA, O’Malley S, Sindelar JL, O’Connor P. Smoking Status is a Clinical Indicator for Alcohol Misuse in U.S. Adults. Archives of Internal Medicine forthcoming.
  15. Olmstead TA, Sindelar JL, Easton CJ, and Carroll KM. The cost-effectiveness of four treatments for marijuana dependence. Addiction Revised and resubmitted.
  16. Olmstead TA, Sindelar JL, and Petry NM. Clinic Variation in the Cost-Effectiveness of Contingency Management. American Journal of Addiction , forthcoming.
  17.  TA and Sindelar JL. For Better or for Worse: The Joint Movement of Health Behaviors of Spouses. Revised and resubmitted.
  18. Sindelar JL, Olmstead T,  and. Peirce J, Cost-effectiveness of Prize Based Contingency Management in Methadone Management Programs. Revised and resubmitted.
  19. Robert Rosenheck ,Douglas Leslie , Jody Sindelar , Edward Miller , Pierre Tariot , Karen Dagerman , Sonia Davis , Barry Lebowitz , Peter Rabins , John Hsaio , Jeffrey Lieberman, Lon Schneider.  A Randomized Trial of the Cost-Effectiveness of Second Generation Antipsychotics and Placebo in the Treatment of Psychosis and Aggression in Alzheimer's Disease, submitted to General Archives of Psychiatry.
  20. McCarty, D et al Sindelar  JL,  Treatment Programs Participating in the National Drug Abuse Treatment Clinical Trials Network. Submitted.

 

Papers in Review or in Progress

 

1.       Sindelar JL and Ball S. Evaluating the Costs of Evidence Based Substance Abuse Treatments. Revised and resubmitted to Perspectives.

2.       Bishai D, Sindelar JL, and Busch SH. What is the optimal subsidy for drug rehabilitation? Evidence from Baltimore City. Revised and resubmitted. Journal of Health Economics.

3.       Snyder A and Sindelar JL. Employment and Earnings Pre and Post Substance Abuse Treatment. Submitted to Journal of Substance Abuse Treatment.

4.       Falba TA, Bayer P, Snyder A, and Sindelar JL. Impact of Peers in Treatment on Treatment Outcomes. Presented at ASHE 2006.

5.       Barry C and Sindelar JL. Design of Insurance Coverage for Alcohol and Drug Abuse Treatment.

6.       Keenan, P and Sindelar JL. SES Disparities in Use of Tobacco Cessation Methods.

 

 

Book Reviews

 

  1. Sindelar JL. Book review of Competition in the Health Care Sector: Ten Years Later, edited by Warren Greenberg, Inquiry, Summer 1986; 26: 309–310.
  2. Sindelar JL. Book review of Medical Care, Medical Costs, The Search for a Health Insurance Policy, by Rashi Fein, Inquiry Spring 1987; 24: 97–98.
  3. Sindelar JL. Book review of Health Care and the Changing Economic Environment, by Alan Sorkin, Journal of Health Administration Education Summer 1987; 469–470.
  4. Sindelar JL. Book Review of Economics and Mental Health, edited by Richard G. Frank and Willard G. Manning, Jr., Inquiry September 1993; 30(2).
  5. Sindelar JL. Book Review of The Costs of Poor Health Habits, edited by Willard Manning, Emmett Keeler, Joseph Newhouse, Elizabeth Sloss, and Jeffery Wasserman, Journal of Economic Literature December 1993; Vol. XXXI: 1993–1994.
  6. Sindelar JL. Book Review of Individual and Social Responsibility: Child Care, Education, Medical Care and Long-term Care in America, edited by Victor R. Fuchs, Journal of Economics Literature March 1997; Vol. XXXV: 150–152.

 

 

Editorials

 

1.     Sindelar JL. “Double the State’s Cigarette Tax.” Op-ed., Hartford Courant 24 January, 2002.

2.     Sindelar JL and Falba T. “New Smoking Ban Would Clear the Air.” Op-ed., Hartford Courant 2 May, 2003.

 

 

Letters, Reports, and Other Publications

 

  1. The Market Structure of Health Insurance: Empirical Estimates. Report to the S. S. Huebner Foundation for Insurance Education, The Wharton School, University of Pennsylvania, November 1983.
  2. Academic Opportunities:  Looking Beyond Economics Departments, with Sindelar JL in American Economic Association, Committee on the Status of Women in the Economic Profession (Newsletter) May 1986.
  3. Intergenerational Transfers to and from the Elderly: Pecuniary and Nonpecuniary Transfers. Final Report to the Joint Economic Committee of Congress; July 1989.

4.     Comments by Sindelar JL in Workshop on Modeling and Forecasting for the 1990s, USDHHS 1990; Publication # HRS-P-OD-90-5, p. 35.

5.     Sindelar JL. Observations on the Value of Physician Work Time. Comments on "Comparisons of the Value of Physician's Time by Specialty" (Marder and Willkie). Regulating Doctors' Fees: Competition, Benefits, and Controls Under Medicare edited by H.E. Frech III. 1991; 282–287.

6.     Sindelar JL. The War on Drugs: Making it a Public Health Battle Women Organizing Women Political Action Committee (WOWPAC) Newsletter October 1998; 1(2): 8–9.

7.     Sindelar JL. Opioid Maintenance: The Politics Matter. Letter to the Editor, Addiction 2001; 96: 1517–1518.

8.     Sindelar JL. What health economists have to say about public health and tobacco. Newsletter of the Committee on the Status of Women in the Economics Profession; Spring 2005.

         

 

            Course Syllabus and Problem Sets Published

 

1.     Sindelar JL. “Health Economics syllabus and reading list.” Compendium of English Language Course Syllabi and Textbooks in Health Economics, edited by M. Hersh-Cochran and K. Cochran, World Health Organization, 1990.

2.     Sindelar JL. “Health Economics syllabus and reading list.” Agricultural Economics, Agricultural Economic Development and Health Economics: Economics Reading Lists, Course Outlines, Exams, Puzzles and Problems, edited by Edward Tower, Eno River Press, pp.170–178, 1985.

3.     Sindelar JL. “Health Economics syllabus and reading list.” Business Administration Reading Lists and Curse Outlines Vol. 14, edited by Richard Porter, Eno River Press, 1981.

 

 

Seminars and Presentations (1999 – Present)

 

Ø       Columbia, NYU, NBER consortium, December 2006.

Ø       Rudd Center, Yale, December 2006.

Ø       Yale School of Management, 2006.

Ø       ASHE peers  (Tracy Falba presented)June 2006

Ø       Paying Drug Users to stay clean,  iHEA, Barcelona, June 2005.

Ø       Economics of Substance Abuse Treatment. University of Miami, April 2005

Ø       RWJF organized conference on Tobacco Policy, Chicago, Novemeber 2005.

Ø       Contigency Management in Substance Abuse Treatment, Addiction Health Services Research, Rand, Sept 2005.

Ø       Smoking, Quitting and Productivity”, Robert Wood Johnson Foundation (RWJF), Tobacco Policy Conference, Chicago, October 2003

Ø       “Public Policy for Recalcitrant Smokers”, Robert Wood Johnson Foundation (RWJF), Tobacco Policy Conference, Chicago, October 2005

Ø       Chicago RWJ 2004, 2005

Ø       Smoking Cessation Policy Findings, Yale TTURC retreat.

Ø       Does the impact of managed care on substance abuse treatment services vary by profit status? Harvard.

Ø       “Smoking Cessation and Public Policy ”, Robert Wood Johnson Foundation (RWJF), Tobacco Policy Conference, Chicago, October 2004

Ø       “Tobacco Spending and its Crowd-out of Other Goods, University of Alabama”, 2004.

Ø       “Non-Profit and For-Profit Substance Abuse Treatment and Managed Care”, MUSC, 2004.

Ø       “Smoking, Quitting and Productivity”, Robert Wood Johnson Foundation (RWJF), Tobacco Policy Conference, Chicago, October 2003

Ø       “Managed Care and Substance Abuse Treatment Services Offered”, Health Services Research conference, Georgia Tech, Atlanta, October, 2003

Ø       “If Smoking Increases Absences, Does Quitting Reduce Them?” International Health Economics Association (iHEA), Biennial Meeting, San Francisco, June 2003

Ø       “The Impact of Managed Care on Substance Abuse Treatment,” Harvard/BU/MIT Health Economics Seminar, April 2003

Ø       “Willingness to Pay as an Evaluation Method in Smoking Cessation,” Transdisciplinary Tobacco Research Use Centers Winter Conference, sponsored by NIC, NIDA, and Robert Wood Johnson Foundation, Phoenix, 2002

Ø       “Cost-Effectiveness Analysis in Evaluations of Two Clinical Trials in NIDA’s Clinical Trial Network”, NIDA sponsored Clinical Trial Network Conference, Charleston, 2002

Ø       “Cost Benefit Analysis of New Smoking Cessation Treatments”, Transdisciplinary Tobacco Use Research, Conference, NIDA/NIC/RWJF sponsored, San Diego, 2001

Ø       “Is Drug Abuse Treatment a Crime Fighting Tool?”  International Health Economics Association, Annual Meeting, York, England July 2001

Ø       “Cost-Effectiveness Analysis in Evaluations of Illicit Drug Prevention,” Center for Substance Abuse Treatment, Washington, DC, May 2001

Ø       “Causal Effects of Illicit Drugs on Crime” Western Economics Association, San Diego, 2000

Ø       “Crime and Drugs”, Association for Health Services Research, Annual Meeting, Chicago, 2000

Ø       “Cost-Benefit Analysis in Evaluations of Illicit Drug Treatments,” NIDA, Washington, DC, October 2000

Ø       “ Causal Effects of Use of Illicit Drugs on Crime”, International Health Economics Annual Meeting, Netherlands, 2000

Ø       “Cost Effectiveness Analysis of Substance Abuse Treatment: Paradox of Multiple Outcomes’.

Ø       Health Service Research in Substance Abuse in Practice, Little Rock Arkansas, 2000

Ø       “Multiple Outcomes in Cost-Effectiveness of Drug Treatment,” International Health Economics

Ø       Association National Meeting, 1999

Ø       “Crime and Drugs,” Western Economics Society, San Diego, 1999

Ø       “Developing a Health Index for Illicit Drug Treatment,” West Haven VA, 1999

Ø       “Cost-Benefit Analysis in Evaluations of Illicit Drug Treatments,” NIDA, Washington, DC, October 1999

Ø       “Cost-Effectiveness of Treatment for Illicit Drug Treatment,” Association for Health Services Research, July 1999

Ø       “Cost-Effectiveness Analysis for Substance Abuse Treatments,” University of Connecticut, May 6, 1999

Ø       “Alcohol and Productivity,” International Health Economics Annual Meeting, Vancouver 1999

 

 

Invited University Seminars (Prior to 1999)

         

Ø       Baruch College, 1994

Ø       Boston University, February 1980; November 1980

Ø       Brandeis University, February 1980

Ø       Brown University, February 1983

Ø       City University of New York, Graduate Center, May 1987

Ø       Cornell University, December 1987, 1995

Ø       Harvard University, March 1979, March 1988

Ø       Johns Hopkins University, January 1988

Ø       Medical University of South Carolina, 1994

Ø       New York University, March 1985, November 1992, March 1993, April 1994

Ø       Stanford University, November 1979

Ø       Tufts University, January 1979

Ø       University of Chicago, January 1979, February 1980, May 1982, October 1983

Ø       University of Illinois, February 1979; November 1983

Ø       University of Michigan, February 1983

Ø       University of North Carolina, March 1979

Ø       University of Pennsylvania, February 1980

Ø       University of Virginia, January 1980

Ø       Vanderbilt University, February 1983

Ø       Wellesley College, February 1980

Ø       Wesleyan College, October 1995

Ø       Yale University, February 1983, 1985, January 1987, May 1987

 

Conference Presentations (Prior to 1999)

                   

Ø       American Economics Association, 1982, 1983, 1984,1985, 1988, 1989, 1994, 1995, 1997

Ø       American Enterprise Institute Conference, April 1989  

Ø       American Population Association, Cincinnati, April 1993

Ø       American Public Health Association, Annual Meeting, October 1988, October 1989, October 1990, November 1992

Ø       Antitrust Division, Department of Justice, May 1988

Ø       Association for Public Policy and Management, October 1992, October 1994

Ø       Economic Costs, Cost-Effectiveness and Financing of Community-Based Drug, NIAAA, Bethesda, MD, October 1991

Ø       Economics of Mental Health, 5th Biannual Conference, June 1990

Ø       Economics of Mental Health, NIMH Conference, April 1988

Ø       Fourth Annual Northeast Regional Research Symposium, VA, 1995

Ø       Health Economics Conference, Johns Hopkins University, May 1992

Ø       Health Economics Conference, Northwestern University, May 1993

Ø       Health Economics Conference, University of Michigan, 1995

Ø       National Bureau of Economic Research Conference on Unions, May 1983

Ø       Health Economist Forum (Chicago), November 1983; March 1984

Ø       Health Economist Forum (Chicago), November 1983; March 1984    

Ø       Illinois Economic Society, October 1980; October 1982

Ø       International Workshop, Health Economics, Institute National de la Statistique et des Etudes Economiques, Paris, France, July, 1995

Ø       National Academy of Science, Expert Panel on Behavioral and Social Factors in Disease Prevention, Funded by the Agency for International Development, 1993

Ø       National Academy of Science, 1994

Ø       National Bureau of Economic Research, Summer Institute, July, 1995

Ø       National Institute of Mental Health Conference on Administrative Issues in Mental Health Services, April 1986

Ø       National Institute on Alcohol Abuse and Alcoholism, Working Group for Prevention Research on Women and Alcohol, Bethesda, MD, 1993

Ø       Rutgers Conference in Health and Regulation, 1995

Ø       Veterans Administration North East Health Economics Conference, 1995

Ø       Western Economics Association Meetings, July 1981; July 1983;

 

 

Other Presentations

 

Ø       CT AMA, New Haven, February 1998

Ø       Donaghue Foundation, February 1994

Ø       Substance Abuse and Mental Health Services Administration, 1994

Ø       NIAAA, Economic and Socioeconomic Issues in the Prevention of Alcohol Related Problems, Treatment; 1990

Ø       Yale Alumni Conference, June 1986

Ø       Health Care Executives Network, Chicago, February 1983

Ø       NBC-WMAQ Radio, Chicago, Health Economics, November 1981

Ø       WLS-TV, Channel 7 Chicago, "Perspectives", February 1981

Ø       Federal Trade Commission, February 1979

 

 

Referee for Journals and Reviewer for Publisher

 

Ø       Addictions

Ø       Archives of General Psychiatry

Ø       Bone

Ø       Canadian Journal of Economics

Ø       Contemporary Policy Issues

Ø       Drug and Alcohol Dependence

Ø       Economic Inquiry

Ø       Health Care Financing Review

Ø       Health Economics (Board of Editors)

Ø       Hospitals and Health Services Administration

Ø       Health Politics, Policy and Law

Ø       Iatrogenics

Ø       Industrial and Labor Relations Review

Ø       Inquiry

Ø       Journal of Behavioral Health Services Research

Ø       Journal of Business

Ø       Journal of Business and Economic Statistics

Ø       Journal of Chronic Disease

Ø       Journal of Clinical Epidemiology

Ø       Journal of Health Economics

Ø       Journal of Human Resources

Ø       Journal of Law, Economics, & Organization

Ø       Journal of Substance Abuse Treatment

Ø       Journal of Political Economy

Ø       Journal of Risk and Insurance

Ø       Medical Care

Ø       Review of Economics and Statistics

Ø       Quarterly Review of Economics and Business

Ø       Scandinavian Journal of Economics

Ø       Milbank Quarterly

Ø       Scott Foresman Publisher

Ø       Southwestern Publisher

 

 

Grants, Awards, and Contracts.

 

As Principal Investigator:

 

1.        National Institute on Drug Abuse (NIDA)

“Economics of Population Health: ASHE Inaugural Conference”

Grant Number: R13 DA022098

Principal Investigator (PI): Jody L. Sindelar

Total Award: $29,000

July 2006 – June 2007

 

2.        National Institute of Aging (NIA)

Grant Number: R01 AG027045

“Work-life, Health Habits, and Health: Longitudinal Analysis of Aging”

Principal Investigator (PI): Jody L. Sindelar

Total award: $1,717,472

March 2006 – February 2010

 

3.        National Institute on Drug Abuse (NIDA)

Grant Number: R01 DA014471

“Economic Evaluations in the CTN: Methods and Applications”

Principal Investigator (PI): Jody L. Sindelar

Total award: $1,579,871

July 2001 – February 2007

 

4.        Robert Wood Johnson Foundation

Grant Number: 039787

“Smokers Who Can’t Quit: Translational Research and Policy Analysis of Risk

Factors”

Principal Investigator (PI): Jody L. Sindelar

Total award:  $1,247,082.

March 2001 – August 2006

 

5.        Robert Wood Johnson Foundation

Grant Number: 039787

“Communicating to Help Smokers Stop Smoking”

Principal Investigator (PI): Jody L. Sindelar

Total award:  $504,000

July 2000 – August 2006

 

6.        Agency for Healthcare Research and Quality (AHRQ)

Grant Number: T32 HS00052

“Training Program in Health Services Research”

Principal Investigator (PI): Jody L. Sindelar

 

7.        National Institute of Alcohol Abuse and Alcoholism (NIAAA), Research Scientist Career Development Award (K02 award)

Grant Number: K02 AA000164

"Economics of Two Generations of Alcoholism on Children"

Principal Investigator (PI): Jody L. Sindelar

Grant Period: July 1993 – June 2000

 

8.        Charles E. Culpepper Foundation, Program on Administration of Justice "Reforming Illicit Drug Policies; A Briefing for Connecticut Legislators"

Principal Investigator (PI): Jody L. Sindelar

Grant Period: October 1996 – December 1999

 

9.        National Institute of Alcohol Abuse and Alcoholism (NIAAA)

Grant Number: R01 AA008394 

"Economics of Alcoholism and Alcohol Consumption"

Principal Investigator (PI): Jody L. Sindelar

Grant Period: January 1990 – December 1993

 

10.    National Center for Health Statistics

Contract to study the effects of parental alcoholism on child health

1990–1991

 

11.    Biomedical Research Services Grant - Internal to EPH small grant fund

Grant Periods: 1984–1985, 1985–1986, and 1988–1989

 

12.    Joint Economic Committee of Congress

Contract to study intergenerational transfers to and from the elderly

Contract Period: 1988

 

13.    S.S. Huebner Foundation for Insurance

Grant on taxation and regulation of health insurance by states, University of Pennsylvania

Grant Period: 1982–1983

 

14.    National Institute of Mental Health (NIMH)

Post-Doctoral Fellowship, University of Chicago

Award Period: 1978–1980

 

15.    Stanford University

Tuition and stipend awards

Award Period: 1972–1975

 

 

As Co-Investigator or Collaborator:

 

1.     National Institute of Alcohol Abuse and Alcoholism (NIAAA)

Grant Number: R03 AA016267

“Investigating Tobacco & Alcohol Use Behaviors Across the Continuum of Use”

Role: Co-Investigator

Principal Investigator (PI): Sherry McKee

September 2005 – August 2007

 

 

2.     National Institute on Drug Abuse (NIDA)

Grant Number: R01 DA019511

“Counseling for Primary Care Office-Based Buprenorphine”
Role: Co-Investigator

Principal Investigator (PI): David Fiellin

August 2005 – July 2010

3.     National Institute on Drug Abuse (NIDA)

Grant Number: P50 DA009241

“Psychotherapy Development Research Center for Cocaine and Opioid Abuse”

Role: Co-Investigator

Principal Investigator (PI): Bruce Rounsaville

July 2005 – June 2009

 

4.     University of Pennsylvania – Subcontract from University of Miami

National Institute on Drug Abuse (NIDA)

Grant Number: P50 DA07705

“Utilizing Clinical and Financial Instruments for Economic Evaluations”

Role: Consultant

Principal Investigator (PI): Michael French

Grant Period: May 2000 – April 2005

 

5.     National Institute on Drug Abuse (NIDA)

“Clinical Antipsychotic Trials of Intervention Effectiveness”

Role: Co-Investigator

Principal Investigator (PI): Robert Rosenheck

Grant Period: December 2000 – December 2004

 

6.     National Institute of Occupational Safety and Health (NIOSH)

Grant Number: R01 OH004182

“Health and Socioeconomic Consequences of NSBRI”

Role: Co-Investigator

Principal Investigator (PI): Carrie Redlich

April 2001 – September 2004

 

7.     National Institute on Drug Abuse (NIDA)

Grant Number: R01 DA15215

“Clinical Trial Network”

Role: Co-Investigator

Principal Investigator (PI): Kathleen Carroll

Grant Period: September 1999 – August 2004

 

8.     National Institute on Drug Abuse (NIDA)

Grant Number: R01 DA12468

“Statistical Methods for Correlated Substance Use Data”

Role: Co-Investigator

Principal Investigator (PI): Heping Zhang

Grant Period: August 2000 – July 2004

 

9.     University of Pennsylvania – Subcontract from University of Miami

National Institute on Drug Abuse (NIDA)

Grant Number: R01 DA11506

“Economic Evaluation Methods: Development and Applications”

Role: Consultant

Principal Investigator (PI): Michael French

Grant Period: September 1998 – August 2003

 

10.   National Institute on Drug Abuse (NIDA)

Grant Number: R01 DA009413

“Combining Behavioral Treatments with Agonist Maintenance”

Role: Co-Investigator

Principal Investigator: Richard Schottenfeld

Grant Period: September 1994 – August 2003

 

11.   National Institute on Drug Abuse (NIDA)

Grant Number: P50 DA009250

“Yale Medications Development Research Center"

Principal Investigator (PI): Thomas Kosten

Grant Period: September 1994 – September 1999

 

12.   National Institute of Mental Health (NIMH)

Grant Number: R24 MH054446

"Connecticut Department of Mental Health and Yale Medications Effectiveness Research Program"

Principal Investigator (PI): Scott Woods

Grant Period: September 1994 – August 1999

 

13.   National Institute on Drug Abuse (NIDA)

Grant Number: R01 DA008754

"Matching Methadone Patients to Psychosocial Treatments"

Role: Co-Investigator

Principal Investigator: Thomas Kosten

Grant Period: September 1993 – August 1997

 

14.   Rockefeller Foundation

"Gender, the Family, and Technological Change in Low Income Countries: A Program of Research and Training"

Role: Co-Investigator

Principal Investigator (PI): Paul Schultz

Grant Period: July 1989 – June 1990